Immunohistochemistry Digital Breast Cancer Panel 3 Test
Comprehensive Breast Cancer Biomarker Analysis
The Immunohistochemistry Digital Breast Cancer Panel 3 Test represents a cutting-edge diagnostic approach for breast cancer evaluation, providing essential information for personalized treatment planning. This advanced panel utilizes immunohistochemistry technology to detect and quantify key biomarkers that determine cancer behavior and treatment responsiveness.
What This Test Measures and Detects
Our comprehensive breast cancer panel evaluates three critical biomarkers that significantly impact treatment decisions and prognosis:
- Estrogen Receptor (ER): Detects the presence of estrogen receptors in cancer cells, indicating whether hormone therapy may be effective
- Progesterone Receptor (PR): Identifies progesterone receptor expression, providing additional information about hormone responsiveness
- HER-2 Protein: Assesses HER-2 receptor overexpression, crucial for determining eligibility for targeted HER-2 therapies
- Photomicrograph Documentation: Provides visual documentation of biomarker expression patterns
- Pathologist Review: Includes expert evaluation to confirm the presence of malignant cells
Who Should Consider This Test
This comprehensive biomarker panel is recommended for individuals who:
- Have been recently diagnosed with breast cancer through biopsy
- Require detailed biomarker analysis for treatment planning
- Need confirmation of hormone receptor status for therapy decisions
- Require HER-2 status determination for targeted treatment eligibility
- Are undergoing evaluation for recurrent breast cancer
- Need comprehensive biomarker profiling for personalized medicine approaches
Key Benefits of the Breast Cancer Panel
Choosing our Immunohistochemistry Digital Breast Cancer Panel 3 Test provides numerous advantages:
- Personalized Treatment Planning: Enables tailored therapy based on individual biomarker profiles
- Improved Prognostic Accuracy: Provides detailed information about cancer behavior and likely treatment response
- Targeted Therapy Selection: Identifies patients who may benefit from specific hormone or HER-2 targeted treatments
- Comprehensive Analysis: Evaluates multiple biomarkers simultaneously for complete assessment
- Expert Interpretation: Includes pathologist review ensuring accurate results and clinical relevance
- Digital Documentation: Provides permanent visual records for future reference and consultation
Understanding Your Test Results
Your test results will provide detailed information about biomarker expression levels:
- ER and PR Status: Positive results indicate hormone receptor expression, suggesting potential response to hormone therapy
- HER-2 Status: Positive results may indicate eligibility for HER-2 targeted therapies like trastuzumab
- Interpretation Guidance: Results include clinical interpretation to help understand treatment implications
- Follow-up Recommendations: Provides guidance on next steps based on biomarker profiles
It’s essential to discuss your results with your healthcare provider to develop an appropriate treatment plan based on your specific biomarker profile.
Test Pricing Information
| Test Name | Regular Price | Discount Price |
|---|---|---|
| Immunohistochemistry Digital Breast Cancer Panel 3 Test | $26 USD | $176 USD |
Nationwide Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, high-quality breast cancer biomarker testing for patients throughout the country.
Book Your Test Today
Take the next step in your breast cancer care with comprehensive biomarker analysis. Our Immunohistochemistry Digital Breast Cancer Panel 3 Test provides the critical information needed for personalized treatment decisions. Contact us today to schedule your test and begin your journey toward targeted, effective cancer care.
Call or WhatsApp: +1(267) 388-9828 to book your appointment or learn more about our comprehensive breast cancer testing services.
